Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy

10.18632/oncotarget.6794

Saved in:

Bibliographic Details
Main Authors:	Neo, S.H, Lew, Q.J, Koh, S.M, Zheng, L, Bi, X, Chao, S.-H
Other Authors:	MICROBIOLOGY AND IMMUNOLOGY
Format:	Article
Published:	2020
Subjects:	antineoplastic agent caspase cell penetrating peptide hexamethylene bisacetamide inducible protein 1 basic region peptide hybrid protein nucleophosmin positive transcription elongation factor b protein p53 unclassified drug HEXIM1 protein, human peptide fragment RNA binding protein TP53 protein, human apoptosis Article breast cancer cell killing cellular distribution controlled study drug cytotoxicity human human cell internalization membrane depolarization mitochondrial membrane potential nucleolus protein expression antagonists and inhibitors Breast Neoplasms cell proliferation female fluorescent antibody technique genetic transcription genetics metabolism pathology tumor cell culture Western blotting Apoptosis Blotting, Western Cell Proliferation Female Fluorescent Antibody Technique Humans Peptide Fragments RNA-Binding Proteins Transcription, Genetic Tumor Cells, Cultured Tumor Suppressor Protein p53
Online Access:	https://scholarbank.nus.edu.sg/handle/10635/180864
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

id	sg-nus-scholar.10635-180864
record_format	dspace
spelling	sg-nus-scholar.10635-1808642024-03-27T08:05:52Z Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy Neo, S.H Lew, Q.J Koh, S.M Zheng, L Bi, X Chao, S.-H MICROBIOLOGY AND IMMUNOLOGY antineoplastic agent caspase cell penetrating peptide hexamethylene bisacetamide inducible protein 1 basic region peptide hybrid protein nucleophosmin positive transcription elongation factor b protein p53 unclassified drug HEXIM1 protein, human peptide fragment protein p53 RNA binding protein TP53 protein, human apoptosis Article breast cancer cell killing cellular distribution controlled study drug cytotoxicity human human cell internalization membrane depolarization mitochondrial membrane potential nucleolus protein expression antagonists and inhibitors apoptosis Breast Neoplasms cell proliferation female fluorescent antibody technique genetic transcription genetics metabolism pathology tumor cell culture Western blotting Apoptosis Blotting, Western Breast Neoplasms Cell Proliferation Female Fluorescent Antibody Technique Humans Peptide Fragments RNA-Binding Proteins Transcription, Genetic Tumor Cells, Cultured Tumor Suppressor Protein p53 10.18632/oncotarget.6794 Oncotarget 7 5 5483-5494 2020-10-27T05:30:36Z 2020-10-27T05:30:36Z 2016 Article Neo, S.H, Lew, Q.J, Koh, S.M, Zheng, L, Bi, X, Chao, S.-H (2016). Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy. Oncotarget 7 (5) : 5483-5494. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.6794 19492553 https://scholarbank.nus.edu.sg/handle/10635/180864 Attribution 4.0 International http://creativecommons.org/licenses/by/4.0/ Unpaywall 20201031
institution	National University of Singapore
building	NUS Library
continent	Asia
country	Singapore Singapore
content_provider	NUS Library
collection	ScholarBank@NUS
topic	antineoplastic agent caspase cell penetrating peptide hexamethylene bisacetamide inducible protein 1 basic region peptide hybrid protein nucleophosmin positive transcription elongation factor b protein p53 unclassified drug HEXIM1 protein, human peptide fragment protein p53 RNA binding protein TP53 protein, human apoptosis Article breast cancer cell killing cellular distribution controlled study drug cytotoxicity human human cell internalization membrane depolarization mitochondrial membrane potential nucleolus protein expression antagonists and inhibitors apoptosis Breast Neoplasms cell proliferation female fluorescent antibody technique genetic transcription genetics metabolism pathology tumor cell culture Western blotting Apoptosis Blotting, Western Breast Neoplasms Cell Proliferation Female Fluorescent Antibody Technique Humans Peptide Fragments RNA-Binding Proteins Transcription, Genetic Tumor Cells, Cultured Tumor Suppressor Protein p53
spellingShingle	antineoplastic agent caspase cell penetrating peptide hexamethylene bisacetamide inducible protein 1 basic region peptide hybrid protein nucleophosmin positive transcription elongation factor b protein p53 unclassified drug HEXIM1 protein, human peptide fragment protein p53 RNA binding protein TP53 protein, human apoptosis Article breast cancer cell killing cellular distribution controlled study drug cytotoxicity human human cell internalization membrane depolarization mitochondrial membrane potential nucleolus protein expression antagonists and inhibitors apoptosis Breast Neoplasms cell proliferation female fluorescent antibody technique genetic transcription genetics metabolism pathology tumor cell culture Western blotting Apoptosis Blotting, Western Breast Neoplasms Cell Proliferation Female Fluorescent Antibody Technique Humans Peptide Fragments RNA-Binding Proteins Transcription, Genetic Tumor Cells, Cultured Tumor Suppressor Protein p53 Neo, S.H Lew, Q.J Koh, S.M Zheng, L Bi, X Chao, S.-H Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy
description	10.18632/oncotarget.6794
author2	MICROBIOLOGY AND IMMUNOLOGY
author_facet	MICROBIOLOGY AND IMMUNOLOGY Neo, S.H Lew, Q.J Koh, S.M Zheng, L Bi, X Chao, S.-H
format	Article
author	Neo, S.H Lew, Q.J Koh, S.M Zheng, L Bi, X Chao, S.-H
author_sort	Neo, S.H
title	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy
title_short	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy
title_full	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy
title_fullStr	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy
title_full_unstemmed	Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy
title_sort	use of a novel cytotoxic hexim1 peptide in the directed breast cancer therapy
publishDate	2020
url	https://scholarbank.nus.edu.sg/handle/10635/180864
_version_	1795301296304029696

Use of a novel cytotoxic HEXIM1 peptide in the directed breast cancer therapy

Similar Items